Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACH: Chlormethine gel in early stage MF-CTCL
NCT04218825Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Clearazide in mycosis fungoides (MF), sponsored by European Organisation for Research and Treatment of Cancer. Started Mar 2022; status: terminated.
02
Drugs
Clearazide
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT04218825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04218825.